top of page

Agenda

Thursday, June 20, 2024

1:00 - 3:00 PM

Disease State Summits (Closed Meetings)


5:30 - 6:00 PM

Dinner

5:30 - 6:15 PM

Industry-Sponsored Event: Ardelyx

Discover a Different Mechanism of Action to Treat Adults With IBS-C: A Case- Based Discussion

Satish Rao, MD


6:15 - 8:00 PM

Welcome Reception

Friday, June 21, 2024

IBD

7:00 - 8:30 AM

Breakfast

 

7:15 - 8:00 AM

Industry Sponsored Event: Eli Lilly

Learn about OMVOH(™️): Some Discoveries
are too Urgent to Ignore

Stephen B. Hanauer, MD Jamie Brogan, APN

8:30–8:35 AM

Welcome to GI ReConnect 2024

Stephen B. Hanauer, MD

8:35–8:55 AM

Biomarkers & Wearables to Track Disease
& Response

Aline Charabaty, MD, AGAF, FACG

9:00–9:20 AM

Will AI Change Our Approach to Mucosal Healing?

Ryan Stidham, MD, MSc

9:25–9:45 AM

Current & Future Utility of IUS for
Disease Monitoring

Rishika Chugh, MD

9:50–10:10 AM

Will Someone Define What Is
Moderate-Severe Disease?

Bruce E. Sands, MD, MS

10:10–10:25 AM

Q&A

10:25–10:40 AM

Break

10:40–11:00 AM

Selecting First Line Advanced Therapies for UC

Stephen B. Hanauer, MD

11:05–11:25 AM

Selecting First Line Advanced Therapies for CD

Sara N Horst, MD, MPH

11:30–11:50 AM

Playing JAKs: Right Patient, Right Time, Right Dose

Russell D. Cohen, MD

11:55 AM–12:15 PM

Combining Therapies for IBD: Rationale and
Practical Aspects

Maria T. Abreu, MD

12:15–12:30 PM

Q&A

12:30 - 1:30 PM

Lunch

1:00 - 1:45 PM

Industry Sponsored Event: Johnson & Johnson

2024 Stelara Real World Evidence in CD & UC

Douglas Nguyen, MD

Saturday, June 22, 2024

7:00 - 8:30 AM

Breakfast

7:15 - 8:00 AM

Industry Sponsored Event: Sanofi/Regeneron

First FDA-Approved Eosinophilic Esophagitis (EoE) Treatment for Adult and Pediatric Patients Aged 1 Year and Older

Fouad Moawad, MD

Novel Diagnostic Approaches

8:30–8:35 AM

Welcome Back

Darren M. Brenner, MD

8:35–8:55 AM

FDA Endpoints for Gastroparesis

Anthony Lembo, MD

8:55–9:15 AM

Novel Capsule Technologies for DGBI and Motility Disorders

Baharak Moshiree, MD

9:15–9:35 AM

Novel Breath Testing Technologies

Satish Rao, MD, PhD

9:35–9:55 AM

When It's Not IBS

Darren M. Brenner, MD

9:55–10:10 AM

Q&A

10:10–10:35 AM

Break

Update on Therapeutics

10:35–10:55 AM

Eosinophilic GI Disorders

Evan S. Dellon, MD, MPH

10:55–11:15 AM

Update on the Management of H. pylori

Wiliam D. Chey, MD

11:15–11:35 AM

Update on C. difficile

Colleen Kelly, MD

11:35–11:55 AM

Microbiome-Based Therapies

Mark Pimentel, MD

11:55 AM–12:15 PM

Update on Treatments for IBS-C and CIC

Lin Chang, MD

12:15–12:30 PM

Q&A

bottom of page